Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

Cited In for PubMed (Select 10397379)

1.

Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases.

Cordel H, Cailhol J, Matheron S, Bloch M, Godineau N, Consigny PH, Gros H, Campa P, Bourée P, Fain O, Ralaimazava P, Bouchaud O.

Malar J. 2013 Nov 7;12:399. doi: 10.1186/1475-2875-12-399.

2.
3.

A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs.

McCarthy JS, Sekuloski S, Griffin PM, Elliott S, Douglas N, Peatey C, Rockett R, O'Rourke P, Marquart L, Hermsen C, Duparc S, Möhrle J, Trenholme KR, Humberstone AJ.

PLoS One. 2011;6(8):e21914. doi: 10.1371/journal.pone.0021914. Epub 2011 Aug 22.

4.

Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.

Happi CT, Gbotosho GO, Folarin OA, Milner D, Sarr O, Sowunmi A, Kyle DE, Milhous WK, Wirth DF, Oduola AM.

Malar J. 2006 Oct 4;5:82.

6.

Antiparasitic agent atovaquone.

Baggish AL, Hill DR.

Antimicrob Agents Chemother. 2002 May;46(5):1163-73. Review. No abstract available.

7.

Effects of atovaquone and diospyrin-based drugs on the cellular ATP of Pneumocystis carinii f. sp. carinii.

Cushion MT, Collins M, Hazra B, Kaneshiro ES.

Antimicrob Agents Chemother. 2000 Mar;44(3):713-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk